UPDATE 1-U.S. FDA approves Gilead's all-oral hepatitis C drug

(Adds company comment, price details, analyst comment, share price)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.